Letter: risk of coeliac disease-do microbial-derived factors promote and protect?

被引：1
|
作者：
Sundqvist, Tommy [1 ]
Stenhammar, Lars [2 ]
Tjellstrom, Bo [2 ,3 ]
Magnusson, Karl-Eric [1 ]
Midtvedt, Tore [3 ]
Norin, Elisabeth [3 ]
Hogberg, Lotta [2 ]
机构：
[1] Linkoping Univ, Div Inflammat & Infect, Dept Clin & Expt Med, Linkoping, Sweden
[2] Linkoping Univ, Dept Clin & Expt Med, Dept Paediat, Norrkoping, Sweden
[3] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 53卷 / 12期
关键词：
D O I：
10.1111/apt.16348
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1326 / 1327
页数：2
相关论文
共 50 条
  • [21] TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism
    Canyelles, Marina
    Plaza, Melania
    Rotllan, Noemi
    Llobet, Dolors
    Julve, Josep
    Mojal, Sergi
    Diaz-Ricart, Maribel
    Manuel Soria, Jose
    Carles Escola-Gil, Joan
    Tondo, Mireia
    Blanco-Vaca, Francisco
    Carles Souto, Joan
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [22] Mesenchymal Stem Cell-Derived Factors Promote Liver Regeneration but Do Not Protect Against Ischemia Reperfusion Injury.
    Fouraschen, Suomi
    van der Laan, Luc
    Wolf, Joshua
    Metselaar, Herold
    de Bruin, Ron
    Tilanus, Hugo
    Olthoff, Kim
    de Jonge, Jeroen
    LIVER TRANSPLANTATION, 2013, 19 : S256 - S256
  • [23] PREVALENCE RATES AND RISK FACTORS FOR OSTEOPOROSIS IN PATIENTS WITH COELIAC DISEASE
    Schembri, J.
    Torpiano, P.
    Azzopardi, N.
    Vassallo, M.
    Ellul, P.
    GUT, 2014, 63 : A261 - A262
  • [24] Letter: coeliac disease and ischaemic heart disease - a true additional risk factor? Authors' reply
    Emilsson, L.
    Carlsson, R.
    James, S.
    Ludvigsson, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (11) : 1118 - 1118
  • [25] Editorial: risk factors for persistent villus atrophy in coeliac disease - is it time to reconsider definitions for refractory coeliac disease?
    Braude, M. R. H.
    Newnham, E. D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1477 - 1478
  • [26] Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
    Raju, Sajan C.
    Molinaro, Antonio
    Awoyemi, Ayodeji
    Jorgensen, Silje F.
    Braadland, Peder R.
    Nendl, Andraz
    Seljeflot, Ingebjorg
    Ueland, Per M.
    Mccann, Adrian
    Aukrust, Pal
    Vestad, Beate
    Mayerhofer, Cristiane
    Broch, Kaspar
    Gullestad, Lars
    Lappegard, Knut T.
    Halvorsen, Bente
    Kristiansen, Karsten
    Hov, Johannes R.
    Troseid, Marius
    GENOME MEDICINE, 2024, 16 (01)
  • [27] Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
    Sajan C. Raju
    Antonio Molinaro
    Ayodeji Awoyemi
    Silje F. Jørgensen
    Peder R. Braadland
    Andraz Nendl
    Ingebjørg Seljeflot
    Per M. Ueland
    Adrian McCann
    Pål Aukrust
    Beate Vestad
    Cristiane Mayerhofer
    Kaspar Broch
    Lars Gullestad
    Knut T. Lappegård
    Bente Halvorsen
    Karsten Kristiansen
    Johannes R. Hov
    Marius Trøseid
    Genome Medicine, 16
  • [28] Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator
    Troy, N.
    Galbraith, S.
    Islam, Z.
    Serralha, M.
    Holt, B.
    Strickland, D.
    Peter, S.
    Anthony, B.
    Holt, P.
    ALLERGY, 2020, 75 : 107 - 107
  • [29] Season and region of birth as risk factors for coeliac disease a key to the aetiology?
    Namatovu, Fredinah
    Lindkvist, Marie
    Olsson, Cecilia
    Ivarsson, Anneli
    Sandstrom, Olof
    ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (12) : 1114 - 1118
  • [30] Immunological Comorbity in Coeliac Disease: Associations, Risk Factors and Clinical Implications
    Luca Elli
    Antonella Bonura
    Daniela Garavaglia
    Eliana Rulli
    Irene Floriani
    Giovanna Tagliabue
    Paolo Contiero
    Maria Teresa Bardella
    Journal of Clinical Immunology, 2012, 32 : 984 - 990
12345